Shoji Yomo

4.6k citations
76 papers · 1.8k indexed · h-index 26
Topics
Meningioma and schwannoma management (40 papers)Brain Metastases and Treatment (31 papers)Glioma Diagnosis and Treatment (26 papers)
Partner nations
JapanFranceUnited States

In The Last Decade

Shoji Yomo

75 papers receiving 1.8k citations

Peers

Shoji Yomo
Comparison fields: 5 of 48
  • Epidemiology 920
  • Pulmonary and Respiratory Medicine 797
  • Neurology 697
  • Genetics 657
  • Oncology 396
Replace Daniel Devriendt with:
Daniel Devriendt Belgium
Patrick E. J. Hanssens Netherlands
Sergio Paolini Italy
Huai‐Che Yang Taiwan
Toru Serizawa Japan
Joseph Bovi United States
Dheerendra Prasad United States
Douglas Kondziolka United States
Cheng-Ying Shiau Taiwan
Steven R. Isaacson United States
Shoji Yomo relative to Daniel Devriendt Belgium Daniel Devriendt's profile →
Citations per field
00.5×6.6×
Daniel Devriendt · 1×
Citations per year

Countries citing papers authored by Shoji Yomo

Since Specialization
Citations

This map shows the geographic impact of Shoji Yomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Yomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Yomo more than expected).

Fields of papers citing papers by Shoji Yomo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoji Yomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Yomo. The network helps show where Shoji Yomo may publish in the future.

Co-authorship network of co-authors of Shoji Yomo

This figure shows the co-authorship network connecting the top 25 collaborators of Shoji Yomo. A scholar is included among the top collaborators of Shoji Yomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoji Yomo. Shoji Yomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 37
5 22
6 45
7 1
8 1
9 12
10 18
11 43
12 21
13 34
14 58
15 16
16 47
17 114
18 39
19 17
20 19

About Shoji Yomo

Shoji Yomo is a scholar working on Genetics, Neurology and Epidemiology, having authored 76 papers that have together received 1.8k indexed citations. Recurring topics across this work include Meningioma and schwannoma management (40 papers), Brain Metastases and Treatment (31 papers) and Glioma Diagnosis and Treatment (26 papers). The work is most often cited by research in Genetics (657 citations), Neurology (697 citations) and Epidemiology (920 citations). Shoji Yomo has collaborated with scholars based in Japan, France and United States. Frequent co-authors include Motohiro Hayashi, Jean Régis, Yasser Arkha, D. Porcheron, Marc Levivier, Jason P. Sheehan, Anne Donnet, Jun Kawagishi, Toru Serizawa and Kazuhiro Oguchi. Their work appears in journals such as Journal of Clinical Oncology, Journal of neurosurgery and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026